Pfizer has agreed to buy privately held UK vaccine developer PowderMed for an undisclosed sum.
PowderMed developed a patented technology to deliver DNA directly to the cells of the body's immune system and is developing vaccine candidates for influenza and chronic viral diseases.
Source: Reuters
No comments:
Post a Comment